Rank | Gene Set | Z-score |
---|---|---|
1 | behavioral response to nicotine (GO:0035095) | 6.62645892 |
2 | histone H4-K12 acetylation (GO:0043983) | 6.62308211 |
3 | neuronal action potential (GO:0019228) | 5.88819515 |
4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.88177399 |
5 | response to pheromone (GO:0019236) | 5.86209181 |
6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.50799331 |
7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.37026280 |
8 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.35151658 |
9 | locomotory exploration behavior (GO:0035641) | 5.11381901 |
10 | positive regulation of action potential (GO:0045760) | 5.10285437 |
11 | protein localization to synapse (GO:0035418) | 5.09385694 |
12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.03062396 |
13 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.02038676 |
14 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.99804092 |
15 | vocalization behavior (GO:0071625) | 4.91941852 |
16 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.90741449 |
17 | synaptic vesicle maturation (GO:0016188) | 4.83542510 |
18 | synaptic vesicle exocytosis (GO:0016079) | 4.80831197 |
19 | glutamate secretion (GO:0014047) | 4.65616261 |
20 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.50858322 |
21 | gamma-aminobutyric acid transport (GO:0015812) | 4.47392249 |
22 | neuron cell-cell adhesion (GO:0007158) | 4.44188106 |
23 | exploration behavior (GO:0035640) | 4.42812667 |
24 | glutamate receptor signaling pathway (GO:0007215) | 4.39446057 |
25 | * regulation of synaptic vesicle transport (GO:1902803) | 4.36723408 |
26 | synaptic transmission, glutamatergic (GO:0035249) | 4.32352044 |
27 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.16347837 |
28 | neuron recognition (GO:0008038) | 4.14704123 |
29 | positive regulation of synapse maturation (GO:0090129) | 4.08366292 |
30 | axonal fasciculation (GO:0007413) | 3.94750484 |
31 | dendritic spine morphogenesis (GO:0060997) | 3.88796704 |
32 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.87866887 |
33 | layer formation in cerebral cortex (GO:0021819) | 3.85694352 |
34 | neurotransmitter secretion (GO:0007269) | 3.82425892 |
35 | cellular response to ATP (GO:0071318) | 3.78047947 |
36 | dendrite morphogenesis (GO:0048813) | 3.77573513 |
37 | neuron-neuron synaptic transmission (GO:0007270) | 3.76320552 |
38 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.71109388 |
39 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.70687417 |
40 | regulation of synapse structural plasticity (GO:0051823) | 3.69364773 |
41 | postsynaptic membrane organization (GO:0001941) | 3.69015311 |
42 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.66911226 |
43 | positive regulation of membrane potential (GO:0045838) | 3.64020095 |
44 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.63383100 |
45 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.61914570 |
46 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.61572191 |
47 | regulation of gene silencing by RNA (GO:0060966) | 3.60615644 |
48 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.60615644 |
49 | regulation of gene silencing by miRNA (GO:0060964) | 3.60615644 |
50 | regulation of postsynaptic membrane potential (GO:0060078) | 3.60310190 |
51 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.60161495 |
52 | action potential (GO:0001508) | 3.59479636 |
53 | regulation of vesicle fusion (GO:0031338) | 3.55137976 |
54 | * long-term memory (GO:0007616) | 3.46444783 |
55 | proline transport (GO:0015824) | 3.44120191 |
56 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 3.42759633 |
57 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 3.42759633 |
58 | regulation of action potential (GO:0098900) | 3.42221951 |
59 | regulation of synaptic plasticity (GO:0048167) | 3.37933978 |
60 | innervation (GO:0060384) | 3.37551128 |
61 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.37537899 |
62 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.37537899 |
63 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.37537899 |
64 | neuron maturation (GO:0042551) | 3.37184113 |
65 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.33096544 |
66 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.32385278 |
67 | interkinetic nuclear migration (GO:0022027) | 3.29698467 |
68 | behavioral response to ethanol (GO:0048149) | 3.29070223 |
69 | neuronal action potential propagation (GO:0019227) | 3.28695929 |
70 | regulation of synapse maturation (GO:0090128) | 3.28607968 |
71 | long-term synaptic potentiation (GO:0060291) | 3.28456375 |
72 | sulfation (GO:0051923) | 3.28434089 |
73 | auditory behavior (GO:0031223) | 3.27925264 |
74 | regulation of neurotransmitter secretion (GO:0046928) | 3.26881945 |
75 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.25735754 |
76 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.24324308 |
77 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.23392040 |
78 | presynaptic membrane assembly (GO:0097105) | 3.21943284 |
79 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 3.21907548 |
80 | mechanosensory behavior (GO:0007638) | 3.21335883 |
81 | parturition (GO:0007567) | 3.20089684 |
82 | behavioral defense response (GO:0002209) | 3.18536724 |
83 | behavioral fear response (GO:0001662) | 3.18536724 |
84 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.17697843 |
85 | ovulation cycle (GO:0042698) | 3.16802325 |
86 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.16589996 |
87 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.16439604 |
88 | fear response (GO:0042596) | 3.14821376 |
89 | nerve growth factor signaling pathway (GO:0038180) | 3.14637734 |
90 | adaptation of signaling pathway (GO:0023058) | 3.14525537 |
91 | synaptic vesicle endocytosis (GO:0048488) | 3.14113836 |
92 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.12963292 |
93 | activation of protein kinase A activity (GO:0034199) | 3.11314122 |
94 | reflex (GO:0060004) | 3.11006921 |
95 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.09706570 |
96 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.09319089 |
97 | response to auditory stimulus (GO:0010996) | 3.08910931 |
98 | positive regulation of mRNA catabolic process (GO:0061014) | 3.08397158 |
99 | cell migration in hindbrain (GO:0021535) | 3.07330893 |
100 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.07292136 |
101 | membrane depolarization (GO:0051899) | 3.06998809 |
102 | dendritic spine organization (GO:0097061) | 3.06230789 |
103 | kynurenine metabolic process (GO:0070189) | 3.06110648 |
104 | transmission of nerve impulse (GO:0019226) | 3.05787302 |
105 | neurotransmitter transport (GO:0006836) | 3.05457920 |
106 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.05394463 |
107 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 3.04498620 |
108 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 3.04498620 |
109 | endoderm formation (GO:0001706) | 3.02283555 |
110 | positive regulation of dendritic spine development (GO:0060999) | 3.02256963 |
111 | cellular potassium ion homeostasis (GO:0030007) | 3.02151023 |
112 | opioid receptor signaling pathway (GO:0038003) | 3.01942599 |
113 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.01696491 |
114 | hindbrain development (GO:0030902) | 3.01395156 |
115 | cell proliferation in forebrain (GO:0021846) | 3.01231118 |
116 | membrane depolarization during action potential (GO:0086010) | 2.98941329 |
117 | neuron remodeling (GO:0016322) | 2.98220528 |
118 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.97669752 |
119 | negative regulation of sodium ion transport (GO:0010766) | 2.97624906 |
120 | synapse assembly (GO:0007416) | 2.95916448 |
121 | central nervous system neuron axonogenesis (GO:0021955) | 2.95456314 |
122 | membrane hyperpolarization (GO:0060081) | 2.94309045 |
123 | tryptophan catabolic process (GO:0006569) | 2.94131167 |
124 | indole-containing compound catabolic process (GO:0042436) | 2.94131167 |
125 | indolalkylamine catabolic process (GO:0046218) | 2.94131167 |
126 | spinal cord motor neuron differentiation (GO:0021522) | 2.93931307 |
127 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.92988096 |
128 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.92240618 |
129 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.91813277 |
130 | protein polyglutamylation (GO:0018095) | 2.91525677 |
131 | glycerophospholipid catabolic process (GO:0046475) | 2.91434308 |
132 | urinary tract smooth muscle contraction (GO:0014848) | 2.89856702 |
133 | cerebellum development (GO:0021549) | 2.89277380 |
134 | positive regulation of neurotransmitter transport (GO:0051590) | 2.86524206 |
135 | regulation of neurotransmitter transport (GO:0051588) | 2.85910161 |
136 | nucleobase catabolic process (GO:0046113) | 2.85081688 |
137 | presynaptic membrane organization (GO:0097090) | 2.85032178 |
138 | detection of calcium ion (GO:0005513) | 2.84527646 |
139 | cardiovascular system development (GO:0072358) | 2.83029798 |
140 | learning (GO:0007612) | 2.82245141 |
141 | regulation of respiratory system process (GO:0044065) | 2.81249596 |
142 | multicellular organismal movement (GO:0050879) | 2.81080720 |
143 | musculoskeletal movement (GO:0050881) | 2.81080720 |
144 | regulation of neurotransmitter levels (GO:0001505) | 2.79771985 |
145 | startle response (GO:0001964) | 2.79645604 |
146 | kidney morphogenesis (GO:0060993) | 2.79191719 |
147 | regulation of dendritic spine development (GO:0060998) | 2.77815862 |
148 | * serotonin metabolic process (GO:0042428) | 2.77584456 |
149 | regulation of ARF protein signal transduction (GO:0032012) | 2.77013895 |
150 | negative regulation of microtubule polymerization (GO:0031115) | 2.77002216 |
151 | vesicle transport along microtubule (GO:0047496) | 2.76558691 |
152 | positive regulation of synaptic transmission (GO:0050806) | 2.76320109 |
153 | somite development (GO:0061053) | 2.76100487 |
154 | * regulation of synaptic transmission (GO:0050804) | 2.76075539 |
155 | cell differentiation in hindbrain (GO:0021533) | 2.76000591 |
156 | regulation of mesoderm development (GO:2000380) | 2.74486650 |
157 | cellular anion homeostasis (GO:0030002) | 2.73918630 |
158 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.73484376 |
159 | dopamine biosynthetic process (GO:0042416) | 2.73296243 |
160 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.73264972 |
161 | peristalsis (GO:0030432) | 2.73097667 |
162 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.69862733 |
163 | synaptic transmission, cholinergic (GO:0007271) | 2.68414720 |
164 | histone H4-K5 acetylation (GO:0043981) | 2.68186404 |
165 | histone H4-K8 acetylation (GO:0043982) | 2.68186404 |
166 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.67408058 |
167 | spinal cord development (GO:0021510) | 2.67143064 |
168 | L-fucose catabolic process (GO:0042355) | 2.64619826 |
169 | fucose catabolic process (GO:0019317) | 2.64619826 |
170 | L-fucose metabolic process (GO:0042354) | 2.64619826 |
171 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.62496376 |
172 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.62250382 |
173 | positive regulation of mRNA 3-end processing (GO:0031442) | 2.62025413 |
174 | forebrain neuron differentiation (GO:0021879) | 2.59291849 |
175 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.58899919 |
176 | indolalkylamine metabolic process (GO:0006586) | 2.58106813 |
177 | dorsal/ventral neural tube patterning (GO:0021904) | 2.55952732 |
178 | cell differentiation in spinal cord (GO:0021515) | 2.55938467 |
179 | positive regulation of fatty acid oxidation (GO:0046321) | 2.55460938 |
180 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.55036960 |
181 | positive regulation of synapse assembly (GO:0051965) | 2.54825470 |
182 | neuronal stem cell maintenance (GO:0097150) | 2.52080591 |
183 | tryptophan metabolic process (GO:0006568) | 2.49967623 |
184 | neuromuscular synaptic transmission (GO:0007274) | 2.46733875 |
185 | regulation of mRNA catabolic process (GO:0061013) | 2.45248273 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 7.40815206 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.77807443 |
3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.02281708 |
4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.92773938 |
5 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.81957561 |
6 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.81452732 |
7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.81158550 |
8 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.59257350 |
9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.51690511 |
10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.51690511 |
11 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.50093486 |
12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.49120157 |
13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.48214973 |
14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.46725566 |
15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.46107458 |
16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.40824457 |
17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.40274237 |
18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.36238877 |
19 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.32257633 |
20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.31316950 |
21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.30982654 |
22 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.29798881 |
23 | VDR_22108803_ChIP-Seq_LS180_Human | 2.29119087 |
24 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.20868637 |
25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.17366879 |
26 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.08934400 |
27 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.06830880 |
28 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.00161064 |
29 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.96583340 |
30 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.89452645 |
31 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.88656102 |
32 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.83452739 |
33 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.77059137 |
34 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.69861256 |
35 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.64854580 |
36 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.64422623 |
37 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.62240213 |
38 | EWS_26573619_Chip-Seq_HEK293_Human | 1.55475998 |
39 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.51946268 |
40 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.49484800 |
41 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.46467070 |
42 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.41488664 |
43 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.40748422 |
44 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.39412530 |
45 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.38054301 |
46 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.37218510 |
47 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.34983090 |
48 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.30821016 |
49 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.30155136 |
50 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.29901444 |
51 | FUS_26573619_Chip-Seq_HEK293_Human | 1.29823223 |
52 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.29795067 |
53 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.28863671 |
54 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.27986269 |
55 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.27070643 |
56 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.26602150 |
57 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.26594691 |
58 | P300_19829295_ChIP-Seq_ESCs_Human | 1.25633772 |
59 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24870182 |
60 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.24771032 |
61 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.24319558 |
62 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.24066000 |
63 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.23065382 |
64 | * AR_19668381_ChIP-Seq_PC3_Human | 1.22545401 |
65 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.22356023 |
66 | STAT3_23295773_ChIP-Seq_U87_Human | 1.22044107 |
67 | AR_25329375_ChIP-Seq_VCAP_Human | 1.20045086 |
68 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17697366 |
69 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.17548723 |
70 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.16763379 |
71 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.15641794 |
72 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.15337607 |
73 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.14985890 |
74 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.14081464 |
75 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14024130 |
76 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.14024130 |
77 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13790044 |
78 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13732036 |
79 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.11399675 |
80 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.10275356 |
81 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10058438 |
82 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.09667929 |
83 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.08264962 |
84 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.07913080 |
85 | KDM2B_26808549_Chip-Seq_K562_Human | 1.07658010 |
86 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.06863563 |
87 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.04641801 |
88 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04542939 |
89 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04249691 |
90 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.03274283 |
91 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.02868114 |
92 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.02183926 |
93 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.02165436 |
94 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.02072023 |
95 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.01946158 |
96 | TCF4_23295773_ChIP-Seq_U87_Human | 1.00582753 |
97 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.00174871 |
98 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.00124817 |
99 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.99593559 |
100 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99095193 |
101 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.99005283 |
102 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.98893725 |
103 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.98451992 |
104 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.98109551 |
105 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.97106355 |
106 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.96726242 |
107 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.95669438 |
108 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.95669438 |
109 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.95210713 |
110 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.94911970 |
111 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.94521126 |
112 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.94477919 |
113 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.94146375 |
114 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.93044947 |
115 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.93044947 |
116 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92882488 |
117 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92733044 |
118 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.92643108 |
119 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92002996 |
120 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91107320 |
121 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89820341 |
122 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.89211637 |
123 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.88425978 |
124 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.87638414 |
125 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.86108800 |
126 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.86089015 |
127 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.85769734 |
128 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.84578200 |
129 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.84436231 |
130 | TP53_16413492_ChIP-PET_HCT116_Human | 0.82107503 |
131 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.81743978 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 6.76633891 |
2 | MP0003880_abnormal_central_pattern | 5.20035865 |
3 | MP0003635_abnormal_synaptic_transmissio | 4.00881448 |
4 | MP0004270_analgesia | 3.32291875 |
5 | MP0002063_abnormal_learning/memory/cond | 3.31622980 |
6 | MP0009745_abnormal_behavioral_response | 3.13298969 |
7 | MP0001968_abnormal_touch/_nociception | 2.89923262 |
8 | MP0002064_seizures | 2.88157078 |
9 | MP0003646_muscle_fatigue | 2.79791356 |
10 | MP0002572_abnormal_emotion/affect_behav | 2.77651336 |
11 | MP0005423_abnormal_somatic_nervous | 2.72133661 |
12 | MP0004133_heterotaxia | 2.62596806 |
13 | MP0001986_abnormal_taste_sensitivity | 2.52547326 |
14 | MP0002735_abnormal_chemical_nociception | 2.51295124 |
15 | MP0009046_muscle_twitch | 2.34560196 |
16 | MP0001486_abnormal_startle_reflex | 2.27826348 |
17 | MP0002736_abnormal_nociception_after | 2.25590074 |
18 | MP0002734_abnormal_mechanical_nocicepti | 2.24317315 |
19 | MP0003195_calcinosis | 2.22141739 |
20 | MP0002272_abnormal_nervous_system | 2.13692487 |
21 | MP0000778_abnormal_nervous_system | 2.10987677 |
22 | MP0002733_abnormal_thermal_nociception | 2.05896948 |
23 | MP0000569_abnormal_digit_pigmentation | 2.03141315 |
24 | MP0001501_abnormal_sleep_pattern | 2.02589643 |
25 | MP0006276_abnormal_autonomic_nervous | 2.02272173 |
26 | MP0003787_abnormal_imprinting | 2.01839369 |
27 | MP0001440_abnormal_grooming_behavior | 1.94894079 |
28 | MP0004858_abnormal_nervous_system | 1.92911373 |
29 | MP0002184_abnormal_innervation | 1.90284732 |
30 | MP0002067_abnormal_sensory_capabilities | 1.89779591 |
31 | MP0002557_abnormal_social/conspecific_i | 1.88009222 |
32 | MP0001970_abnormal_pain_threshold | 1.83838310 |
33 | MP0003136_yellow_coat_color | 1.83194309 |
34 | MP0001502_abnormal_circadian_rhythm | 1.79708859 |
35 | MP0002909_abnormal_adrenal_gland | 1.78822841 |
36 | MP0004811_abnormal_neuron_physiology | 1.77816825 |
37 | MP0008961_abnormal_basal_metabolism | 1.77265286 |
38 | MP0002160_abnormal_reproductive_system | 1.75002097 |
39 | MP0003119_abnormal_digestive_system | 1.74963990 |
40 | MP0003183_abnormal_peptide_metabolism | 1.72983529 |
41 | MP0004130_abnormal_muscle_cell | 1.69576170 |
42 | MP0003122_maternal_imprinting | 1.66454579 |
43 | MP0010386_abnormal_urinary_bladder | 1.65580115 |
44 | MP0008569_lethality_at_weaning | 1.65388167 |
45 | MP0001984_abnormal_olfaction | 1.61732721 |
46 | MP0001485_abnormal_pinna_reflex | 1.61469783 |
47 | MP0005646_abnormal_pituitary_gland | 1.60968057 |
48 | MP0008877_abnormal_DNA_methylation | 1.60460372 |
49 | MP0009780_abnormal_chondrocyte_physiolo | 1.56279837 |
50 | MP0000955_abnormal_spinal_cord | 1.54327124 |
51 | MP0002638_abnormal_pupillary_reflex | 1.46329108 |
52 | MP0002882_abnormal_neuron_morphology | 1.46017813 |
53 | MP0005389_reproductive_system_phenotype | 1.44526003 |
54 | MP0005645_abnormal_hypothalamus_physiol | 1.43903091 |
55 | MP0000427_abnormal_hair_cycle | 1.41739430 |
56 | MP0003879_abnormal_hair_cell | 1.41012220 |
57 | MP0005386_behavior/neurological_phenoty | 1.38936978 |
58 | MP0004924_abnormal_behavior | 1.38936978 |
59 | MP0002822_catalepsy | 1.38594513 |
60 | MP0002066_abnormal_motor_capabilities/c | 1.32572012 |
61 | MP0010030_abnormal_orbit_morphology | 1.30765878 |
62 | MP0001188_hyperpigmentation | 1.29880275 |
63 | MP0003315_abnormal_perineum_morphology | 1.24964826 |
64 | MP0000534_abnormal_ureter_morphology | 1.23650262 |
65 | MP0003329_amyloid_beta_deposits | 1.22621865 |
66 | MP0006292_abnormal_olfactory_placode | 1.21371953 |
67 | MP0002653_abnormal_ependyma_morphology | 1.20702850 |
68 | MP0002152_abnormal_brain_morphology | 1.14199293 |
69 | MP0003011_delayed_dark_adaptation | 1.11458316 |
70 | MP0001905_abnormal_dopamine_level | 1.10739018 |
71 | MP0005551_abnormal_eye_electrophysiolog | 1.06694283 |
72 | MP0004510_myositis | 1.06542934 |
73 | MP0002069_abnormal_eating/drinking_beha | 1.05250815 |
74 | MP0003172_abnormal_lysosome_physiology | 1.05053619 |
75 | MP0005174_abnormal_tail_pigmentation | 1.04792469 |
76 | MP0003942_abnormal_urinary_system | 1.04294242 |
77 | MP0003633_abnormal_nervous_system | 1.03521085 |
78 | MP0000230_abnormal_systemic_arterial | 1.02554810 |
79 | MP0000049_abnormal_middle_ear | 1.01801242 |
80 | MP0004043_abnormal_pH_regulation | 1.01486545 |
81 | MP0005535_abnormal_body_temperature | 0.98926476 |
82 | MP0002089_abnormal_postnatal_growth/wei | 0.98863169 |
83 | MP0000631_abnormal_neuroendocrine_gland | 0.97809234 |
84 | MP0004885_abnormal_endolymph | 0.97322970 |
85 | MP0001529_abnormal_vocalization | 0.96514873 |
86 | MP0005448_abnormal_energy_balance | 0.94023924 |
87 | MP0000026_abnormal_inner_ear | 0.91945735 |
88 | MP0004742_abnormal_vestibular_system | 0.91426927 |
89 | MP0002229_neurodegeneration | 0.90787692 |
90 | MP0004142_abnormal_muscle_tone | 0.90189421 |
91 | MP0005248_abnormal_Harderian_gland | 0.89412295 |
92 | MP0003632_abnormal_nervous_system | 0.87143492 |
93 | MP0001765_abnormal_ion_homeostasis | 0.87081395 |
94 | MP0009250_abnormal_appendicular_skeleto | 0.85154723 |
95 | MP0005195_abnormal_posterior_eye | 0.84519647 |
96 | MP0001919_abnormal_reproductive_system | 0.84286457 |
97 | MP0005394_taste/olfaction_phenotype | 0.84069607 |
98 | MP0005499_abnormal_olfactory_system | 0.84069607 |
99 | MP0003303_peritoneal_inflammation | 0.83713002 |
100 | MP0003283_abnormal_digestive_organ | 0.82251404 |
101 | MP0002928_abnormal_bile_duct | 0.82225855 |
102 | MP0003631_nervous_system_phenotype | 0.80870777 |
103 | MP0003937_abnormal_limbs/digits/tail_de | 0.80021002 |
104 | MP0002277_abnormal_respiratory_mucosa | 0.79036395 |
105 | MP0001664_abnormal_digestion | 0.78834236 |
106 | MP0003938_abnormal_ear_development | 0.78786506 |
107 | MP0008872_abnormal_physiological_respon | 0.77645851 |
108 | MP0003959_abnormal_lean_body | 0.75266502 |
109 | MP0008775_abnormal_heart_ventricle | 0.75218697 |
110 | MP0005083_abnormal_biliary_tract | 0.74936784 |
111 | MP0002234_abnormal_pharynx_morphology | 0.73921630 |
112 | MP0002752_abnormal_somatic_nervous | 0.73663972 |
113 | MP0006072_abnormal_retinal_apoptosis | 0.73320083 |
114 | MP0001963_abnormal_hearing_physiology | 0.73309489 |
115 | MP0003121_genomic_imprinting | 0.72727440 |
116 | MP0002876_abnormal_thyroid_physiology | 0.71582048 |
117 | MP0005253_abnormal_eye_physiology | 0.71143225 |
118 | MP0003861_abnormal_nervous_system | 0.69250834 |
119 | MP0004085_abnormal_heartbeat | 0.68254215 |
120 | MP0008874_decreased_physiological_sensi | 0.68183002 |
121 | MP0002102_abnormal_ear_morphology | 0.67720046 |
122 | MP0002837_dystrophic_cardiac_calcinosis | 0.67249843 |
123 | MP0005171_absent_coat_pigmentation | 0.65911609 |
124 | MP0003075_altered_response_to | 0.64715955 |
125 | MP0005187_abnormal_penis_morphology | 0.63534341 |
126 | MP0002138_abnormal_hepatobiliary_system | 0.62787366 |
127 | MP0005379_endocrine/exocrine_gland_phen | 0.62489753 |
128 | MP0003634_abnormal_glial_cell | 0.61916558 |
129 | MP0002090_abnormal_vision | 0.61654315 |
130 | MP0009379_abnormal_foot_pigmentation | 0.61612423 |
131 | MP0000678_abnormal_parathyroid_gland | 0.61492323 |
132 | MP0001177_atelectasis | 0.61262213 |
133 | MP0004145_abnormal_muscle_electrophysio | 0.60964400 |
134 | MP0003137_abnormal_impulse_conducting | 0.60713647 |
135 | MP0002751_abnormal_autonomic_nervous | 0.60629407 |
136 | MP0003890_abnormal_embryonic-extraembry | 0.59484529 |
137 | MP0000015_abnormal_ear_pigmentation | 0.59412720 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 6.06554688 |
2 | Myokymia (HP:0002411) | 5.31884244 |
3 | Focal seizures (HP:0007359) | 4.69720664 |
4 | Epileptic encephalopathy (HP:0200134) | 4.63483907 |
5 | Visual hallucinations (HP:0002367) | 4.56531286 |
6 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 4.52628815 |
7 | Abnormality of alanine metabolism (HP:0010916) | 4.52628815 |
8 | Hyperalaninemia (HP:0003348) | 4.52628815 |
9 | Progressive cerebellar ataxia (HP:0002073) | 4.17513673 |
10 | Febrile seizures (HP:0002373) | 4.10265452 |
11 | Abnormality of the lower motor neuron (HP:0002366) | 3.82167728 |
12 | Supranuclear gaze palsy (HP:0000605) | 3.79987171 |
13 | Pancreatic cysts (HP:0001737) | 3.70043169 |
14 | Atonic seizures (HP:0010819) | 3.69373194 |
15 | Excessive salivation (HP:0003781) | 3.64269311 |
16 | Drooling (HP:0002307) | 3.64269311 |
17 | Decreased circulating renin level (HP:0003351) | 3.62411093 |
18 | Hyperventilation (HP:0002883) | 3.56341676 |
19 | Absence seizures (HP:0002121) | 3.56320939 |
20 | Amblyopia (HP:0000646) | 3.54614874 |
21 | Abnormality of secondary sexual hair (HP:0009888) | 3.37108442 |
22 | Abnormality of the axillary hair (HP:0100134) | 3.37108442 |
23 | Congenital stationary night blindness (HP:0007642) | 3.36122369 |
24 | Nephronophthisis (HP:0000090) | 3.32234587 |
25 | Dialeptic seizures (HP:0011146) | 3.29079971 |
26 | True hermaphroditism (HP:0010459) | 3.27858127 |
27 | Pancreatic fibrosis (HP:0100732) | 3.27844289 |
28 | Ankle clonus (HP:0011448) | 3.23450354 |
29 | Abnormality of midbrain morphology (HP:0002418) | 3.21925999 |
30 | Molar tooth sign on MRI (HP:0002419) | 3.21925999 |
31 | Broad-based gait (HP:0002136) | 3.17956841 |
32 | Abnormal pancreas size (HP:0012094) | 3.10254355 |
33 | Mutism (HP:0002300) | 3.07105244 |
34 | Genetic anticipation (HP:0003743) | 3.07017245 |
35 | Clumsiness (HP:0002312) | 3.02356321 |
36 | Depression (HP:0000716) | 2.96788704 |
37 | Hyperactive renin-angiotensin system (HP:0000841) | 2.95801408 |
38 | Protruding tongue (HP:0010808) | 2.95596772 |
39 | Epileptiform EEG discharges (HP:0011182) | 2.94688002 |
40 | Congenital sensorineural hearing impairment (HP:0008527) | 2.92645222 |
41 | Papilledema (HP:0001085) | 2.89286444 |
42 | Generalized tonic-clonic seizures (HP:0002069) | 2.87217295 |
43 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.86484143 |
44 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.86484143 |
45 | Birth length less than 3rd percentile (HP:0003561) | 2.86286857 |
46 | Poor eye contact (HP:0000817) | 2.84924571 |
47 | Bone cyst (HP:0012062) | 2.82852547 |
48 | Osteomalacia (HP:0002749) | 2.80696178 |
49 | EEG with generalized epileptiform discharges (HP:0011198) | 2.78648353 |
50 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.78124537 |
51 | Truncal ataxia (HP:0002078) | 2.77537493 |
52 | Abnormality of the renal medulla (HP:0100957) | 2.77215905 |
53 | Furrowed tongue (HP:0000221) | 2.72605105 |
54 | Irregular vertebral endplates (HP:0003301) | 2.71596971 |
55 | Stereotypic behavior (HP:0000733) | 2.66789789 |
56 | Action tremor (HP:0002345) | 2.66104445 |
57 | Abnormality of the vertebral endplates (HP:0005106) | 2.65135711 |
58 | Tubular atrophy (HP:0000092) | 2.64066964 |
59 | Dysmetria (HP:0001310) | 2.61643862 |
60 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.59465378 |
61 | Absent speech (HP:0001344) | 2.57925417 |
62 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.56712738 |
63 | Gaze-evoked nystagmus (HP:0000640) | 2.55761003 |
64 | Failure to thrive in infancy (HP:0001531) | 2.55142598 |
65 | Impaired smooth pursuit (HP:0007772) | 2.53021090 |
66 | Hyperkalemia (HP:0002153) | 2.52646517 |
67 | Agitation (HP:0000713) | 2.51982080 |
68 | Hypsarrhythmia (HP:0002521) | 2.49868966 |
69 | Dysdiadochokinesis (HP:0002075) | 2.49306541 |
70 | Anxiety (HP:0000739) | 2.45675114 |
71 | Impaired social interactions (HP:0000735) | 2.42581233 |
72 | Abnormal social behavior (HP:0012433) | 2.42581233 |
73 | Hemiparesis (HP:0001269) | 2.40560944 |
74 | Patellar aplasia (HP:0006443) | 2.40353170 |
75 | Amyotrophic lateral sclerosis (HP:0007354) | 2.40111366 |
76 | Abnormal eating behavior (HP:0100738) | 2.39989154 |
77 | Pheochromocytoma (HP:0002666) | 2.38198337 |
78 | Type II lissencephaly (HP:0007260) | 2.35144397 |
79 | Large for gestational age (HP:0001520) | 2.34457242 |
80 | Curly hair (HP:0002212) | 2.33744973 |
81 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.33722606 |
82 | Inappropriate behavior (HP:0000719) | 2.32637230 |
83 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.30304277 |
84 | Inability to walk (HP:0002540) | 2.30100596 |
85 | Progressive inability to walk (HP:0002505) | 2.29918857 |
86 | Urinary urgency (HP:0000012) | 2.29770637 |
87 | Tinnitus (HP:0000360) | 2.29135427 |
88 | Spastic gait (HP:0002064) | 2.28487252 |
89 | Congenital, generalized hypertrichosis (HP:0004540) | 2.28247517 |
90 | Gait imbalance (HP:0002141) | 2.28171330 |
91 | Hyperaldosteronism (HP:0000859) | 2.28006927 |
92 | Cystic liver disease (HP:0006706) | 2.26912494 |
93 | Ulnar claw (HP:0001178) | 2.26792860 |
94 | Abnormality of salivation (HP:0100755) | 2.26004940 |
95 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.24926963 |
96 | Chorioretinal atrophy (HP:0000533) | 2.24489416 |
97 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.23572320 |
98 | Absent/shortened dynein arms (HP:0200106) | 2.23572320 |
99 | Partial agenesis of the corpus callosum (HP:0001338) | 2.20637772 |
100 | Conjunctival hamartoma (HP:0100780) | 2.18994696 |
101 | Hip contracture (HP:0003273) | 2.17929189 |
102 | Deep palmar crease (HP:0006191) | 2.15738181 |
103 | Open mouth (HP:0000194) | 2.12676538 |
104 | Blue irides (HP:0000635) | 2.10120642 |
105 | Pendular nystagmus (HP:0012043) | 2.08479430 |
106 | Polyphagia (HP:0002591) | 2.08291292 |
107 | Postural instability (HP:0002172) | 2.05881483 |
108 | Neuroendocrine neoplasm (HP:0100634) | 2.04945325 |
109 | Diplopia (HP:0000651) | 2.04781246 |
110 | Abnormality of binocular vision (HP:0011514) | 2.04781246 |
111 | Large eyes (HP:0001090) | 2.03737905 |
112 | Cerebral inclusion bodies (HP:0100314) | 2.03076097 |
113 | Anophthalmia (HP:0000528) | 2.01354577 |
114 | Attenuation of retinal blood vessels (HP:0007843) | 2.00380326 |
115 | Prominent supraorbital ridges (HP:0000336) | 2.00338616 |
116 | Limb dystonia (HP:0002451) | 2.00051133 |
117 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.00012938 |
118 | Tented upper lip vermilion (HP:0010804) | 1.98469552 |
119 | Male pseudohermaphroditism (HP:0000037) | 1.98184190 |
120 | Lissencephaly (HP:0001339) | 1.97774808 |
121 | Nephrogenic diabetes insipidus (HP:0009806) | 1.97578109 |
122 | Bradykinesia (HP:0002067) | 1.96617851 |
123 | Apathy (HP:0000741) | 1.96071483 |
124 | Obstructive sleep apnea (HP:0002870) | 1.95740706 |
125 | Exotropia (HP:0000577) | 1.95317800 |
126 | Chronic otitis media (HP:0000389) | 1.95093780 |
127 | Pointed chin (HP:0000307) | 1.94979299 |
128 | Abolished electroretinogram (ERG) (HP:0000550) | 1.94006703 |
129 | Meningioma (HP:0002858) | 1.92738594 |
130 | Scanning speech (HP:0002168) | 1.92524936 |
131 | Neurodegeneration (HP:0002180) | 1.91996807 |
132 | Sclerocornea (HP:0000647) | 1.91413756 |
133 | Esotropia (HP:0000565) | 1.91281343 |
134 | Macroorchidism (HP:0000053) | 1.91090284 |
135 | Confusion (HP:0001289) | 1.90880889 |
136 | Hemiplegia (HP:0002301) | 1.90742579 |
137 | Psychosis (HP:0000709) | 1.90031335 |
138 | Specific learning disability (HP:0001328) | 1.87932887 |
139 | Medial flaring of the eyebrow (HP:0010747) | 1.87157234 |
140 | Hypoplasia of the brainstem (HP:0002365) | 1.86226624 |
141 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.86226624 |
142 | Diminished motivation (HP:0000745) | 1.85987922 |
143 | Hamartoma of the eye (HP:0010568) | 1.85367475 |
144 | Neurofibrillary tangles (HP:0002185) | 1.84850873 |
145 | Annular pancreas (HP:0001734) | 1.83800965 |
146 | Fair hair (HP:0002286) | 1.83034217 |
147 | Abnormality of the nasal septum (HP:0000419) | 1.82626406 |
148 | Generalized hypopigmentation of hair (HP:0011358) | 1.82511721 |
149 | Limited hip movement (HP:0008800) | 1.82007948 |
150 | Macroglossia (HP:0000158) | 1.81975165 |
151 | Optic nerve hypoplasia (HP:0000609) | 1.81443168 |
152 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.81352862 |
153 | Focal dystonia (HP:0004373) | 1.81136380 |
154 | Lower limb muscle weakness (HP:0007340) | 1.80128480 |
155 | Sleep apnea (HP:0010535) | 1.80016865 |
156 | Torticollis (HP:0000473) | 1.79936748 |
157 | Abnormality of the renal cortex (HP:0011035) | 1.79675994 |
158 | Abnormality of the corticospinal tract (HP:0002492) | 1.79000487 |
159 | Tubulointerstitial fibrosis (HP:0005576) | 1.78858925 |
160 | Hypoventilation (HP:0002791) | 1.78622224 |
161 | Ventricular fibrillation (HP:0001663) | 1.78466648 |
162 | Insomnia (HP:0100785) | 1.78064765 |
163 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.76802511 |
164 | Absent hair (HP:0002298) | 1.76611303 |
165 | Increased corneal curvature (HP:0100692) | 1.76401127 |
166 | Keratoconus (HP:0000563) | 1.76401127 |
167 | Spinal muscular atrophy (HP:0007269) | 1.75737922 |
168 | Short hallux (HP:0010109) | 1.75650993 |
169 | Hypoplastic ischia (HP:0003175) | 1.75649666 |
170 | Decreased central vision (HP:0007663) | 1.75054956 |
171 | Mesangial abnormality (HP:0001966) | 1.74469907 |
172 | Concave nail (HP:0001598) | 1.73712668 |
173 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.73663038 |
174 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.72987127 |
175 | Abnormal drinking behavior (HP:0030082) | 1.69802093 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NTRK3 | 4.77504393 |
2 | FRK | 4.71097618 |
3 | ACVR1B | 4.30407286 |
4 | MARK1 | 4.14828829 |
5 | EPHA4 | 3.79979424 |
6 | ADRBK2 | 3.64365543 |
7 | MAP3K9 | 3.54839649 |
8 | PNCK | 3.51278091 |
9 | BMPR1B | 3.23887811 |
10 | MAP3K4 | 2.67057279 |
11 | MAP2K7 | 2.65194384 |
12 | TLK1 | 2.57686213 |
13 | MINK1 | 2.44053087 |
14 | DAPK2 | 2.43279443 |
15 | TNIK | 2.32881855 |
16 | ZAK | 2.30680477 |
17 | CASK | 2.25832044 |
18 | SIK2 | 2.19357365 |
19 | NTRK2 | 2.06974989 |
20 | GRK1 | 2.03702343 |
21 | PRKD3 | 1.92589556 |
22 | FES | 1.89084185 |
23 | KSR1 | 1.84640791 |
24 | PAK6 | 1.83432503 |
25 | PINK1 | 1.80593661 |
26 | RIPK4 | 1.80190384 |
27 | MAPK13 | 1.79640915 |
28 | LMTK2 | 1.76750610 |
29 | DAPK1 | 1.63481240 |
30 | KSR2 | 1.62682500 |
31 | MAP3K2 | 1.59799636 |
32 | PRPF4B | 1.56403546 |
33 | TGFBR1 | 1.54528171 |
34 | CDK5 | 1.50498152 |
35 | MAP3K12 | 1.49390740 |
36 | NTRK1 | 1.46498907 |
37 | GRK5 | 1.46080780 |
38 | MAP2K4 | 1.42058808 |
39 | UHMK1 | 1.39731243 |
40 | CAMKK1 | 1.27252291 |
41 | MARK2 | 1.23952920 |
42 | TYRO3 | 1.22154680 |
43 | STK38 | 1.09776810 |
44 | MAP3K13 | 1.06617749 |
45 | WNK4 | 1.06154823 |
46 | RPS6KA6 | 1.01018679 |
47 | NEK9 | 1.00963065 |
48 | PRKCG | 0.99181834 |
49 | PTK2B | 0.99077970 |
50 | MKNK2 | 0.96558822 |
51 | CAMK1 | 0.96274577 |
52 | WNK3 | 0.96058964 |
53 | PIK3CA | 0.93743263 |
54 | DYRK1A | 0.92323185 |
55 | RPS6KA4 | 0.90693124 |
56 | PLK2 | 0.89097938 |
57 | CDK19 | 0.86635435 |
58 | CAMK2A | 0.86525052 |
59 | NME1 | 0.84802851 |
60 | CSNK1G2 | 0.81771715 |
61 | TRPM7 | 0.81624812 |
62 | SIK3 | 0.79725894 |
63 | PHKG1 | 0.79639796 |
64 | PHKG2 | 0.79639796 |
65 | SGK494 | 0.77877863 |
66 | SGK223 | 0.77877863 |
67 | PRKCQ | 0.77465172 |
68 | TAOK1 | 0.76711302 |
69 | CAMK1D | 0.76128105 |
70 | RPS6KA5 | 0.75466413 |
71 | ICK | 0.74100745 |
72 | MAP3K7 | 0.73612336 |
73 | MAP2K1 | 0.73291929 |
74 | RET | 0.72991248 |
75 | IRAK1 | 0.72465231 |
76 | SCYL2 | 0.69498581 |
77 | RAF1 | 0.66972934 |
78 | MAP3K1 | 0.66930557 |
79 | PAK3 | 0.66290424 |
80 | CAMK4 | 0.65087643 |
81 | CAMK2B | 0.64864973 |
82 | SGK1 | 0.64375050 |
83 | CDK18 | 0.64205573 |
84 | DYRK2 | 0.64104449 |
85 | NEK2 | 0.64034844 |
86 | ERBB2 | 0.61229959 |
87 | STK11 | 0.60265078 |
88 | SGK2 | 0.59810104 |
89 | CDK15 | 0.59528926 |
90 | PKN1 | 0.59471327 |
91 | HIPK2 | 0.58054672 |
92 | PRKCZ | 0.57373635 |
93 | CDK14 | 0.55135732 |
94 | PRKCH | 0.54421048 |
95 | TAOK2 | 0.54302152 |
96 | BMPR2 | 0.53481072 |
97 | PDGFRB | 0.52873656 |
98 | CDK3 | 0.52660312 |
99 | CDK11A | 0.52451661 |
100 | FGR | 0.52126059 |
101 | IRAK4 | 0.52027392 |
102 | PDK1 | 0.51275265 |
103 | CAMK1G | 0.50933007 |
104 | CHUK | 0.50238297 |
105 | CDC42BPA | 0.49517927 |
106 | TAOK3 | 0.48583078 |
107 | TIE1 | 0.48570112 |
108 | INSRR | 0.46630741 |
109 | PRKACA | 0.45286162 |
110 | NUAK1 | 0.44500586 |
111 | RPS6KA2 | 0.43498092 |
112 | RPS6KA3 | 0.43217496 |
113 | FYN | 0.42987680 |
114 | SGK3 | 0.40809181 |
115 | MAP2K2 | 0.40801669 |
116 | PRKCE | 0.40670443 |
117 | PLK4 | 0.40453139 |
118 | FER | 0.40182329 |
119 | BRAF | 0.38941150 |
120 | DYRK3 | 0.38650127 |
121 | CAMKK2 | 0.38635563 |
122 | GRK6 | 0.38262321 |
123 | MAPK12 | 0.37963918 |
124 | WNK1 | 0.37148681 |
125 | GRK7 | 0.36491128 |
126 | SYK | 0.35842606 |
127 | MAPK15 | 0.35786367 |
128 | AKT3 | 0.35301706 |
129 | MAPK10 | 0.34930148 |
130 | PRKAA1 | 0.34896240 |
131 | ERBB3 | 0.33771313 |
132 | PRKD2 | 0.33377352 |
133 | ALK | 0.33178704 |
134 | PDPK1 | 0.32909240 |
135 | ARAF | 0.32256380 |
136 | PDGFRA | 0.31709810 |
137 | ADRBK1 | 0.30345189 |
138 | DAPK3 | 0.30138575 |
139 | OXSR1 | 0.30109015 |
140 | MELK | 0.28906010 |
141 | PRKCB | 0.28678910 |
142 | CSNK1D | 0.27895540 |
143 | MAPK9 | 0.27856365 |
144 | EPHB2 | 0.27752021 |
145 | IKBKB | 0.25823581 |
146 | CSNK1A1 | 0.24518316 |
147 | MAP3K11 | 0.24278277 |
148 | PRKCA | 0.24118368 |
149 | PRKACG | 0.24010376 |
150 | PRKAA2 | 0.22067641 |
151 | TEC | 0.21587040 |
152 | MUSK | 0.21341329 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.46034137 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.88752171 |
3 | Circadian entrainment_Homo sapiens_hsa04713 | 2.79054018 |
4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.71649762 |
5 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.66376865 |
6 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.57334488 |
7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.50868236 |
8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.49940611 |
9 | Olfactory transduction_Homo sapiens_hsa04740 | 2.45100517 |
10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.42841296 |
11 | GABAergic synapse_Homo sapiens_hsa04727 | 2.38758022 |
12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.38591274 |
13 | Morphine addiction_Homo sapiens_hsa05032 | 2.32645179 |
14 | Insulin secretion_Homo sapiens_hsa04911 | 2.28543174 |
15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.18415962 |
16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.14815720 |
17 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.03507812 |
18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 2.01182905 |
19 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.94693357 |
20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.94480164 |
21 | Salivary secretion_Homo sapiens_hsa04970 | 1.93379993 |
22 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.86137862 |
23 | Taste transduction_Homo sapiens_hsa04742 | 1.81106255 |
24 | Long-term depression_Homo sapiens_hsa04730 | 1.72975491 |
25 | Renin secretion_Homo sapiens_hsa04924 | 1.70846610 |
26 | Cocaine addiction_Homo sapiens_hsa05030 | 1.69523129 |
27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.63391436 |
28 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.63323105 |
29 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.63097158 |
30 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.56804752 |
31 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.53477652 |
32 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.49720358 |
33 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.48708597 |
34 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.44970934 |
35 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.39351988 |
36 | Phototransduction_Homo sapiens_hsa04744 | 1.36350946 |
37 | Gap junction_Homo sapiens_hsa04540 | 1.33723648 |
38 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.31293768 |
39 | Axon guidance_Homo sapiens_hsa04360 | 1.30827163 |
40 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.30374817 |
41 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.28733429 |
42 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.27591854 |
43 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.26906110 |
44 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.23417795 |
45 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.22366652 |
46 | Glioma_Homo sapiens_hsa05214 | 1.17437785 |
47 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.15826370 |
48 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.13645973 |
49 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.13088282 |
50 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.11805642 |
51 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.11108360 |
52 | ABC transporters_Homo sapiens_hsa02010 | 1.06400107 |
53 | Melanogenesis_Homo sapiens_hsa04916 | 1.00967699 |
54 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.99036222 |
55 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.98676980 |
56 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.97782900 |
57 | Circadian rhythm_Homo sapiens_hsa04710 | 0.95474615 |
58 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.93977031 |
59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.90665556 |
60 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.90508323 |
61 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.89702992 |
62 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.86697599 |
63 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.86648900 |
64 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.85707324 |
65 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.84909245 |
66 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.84611540 |
67 | Melanoma_Homo sapiens_hsa05218 | 0.83193924 |
68 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.83158475 |
69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.82216930 |
70 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.80828708 |
71 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.80332010 |
72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.77560204 |
73 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.77125764 |
74 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.76159385 |
75 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.75913265 |
76 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74811879 |
77 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.74352422 |
78 | Sulfur relay system_Homo sapiens_hsa04122 | 0.72679984 |
79 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.71906583 |
80 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.71328989 |
81 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.71287620 |
82 | Histidine metabolism_Homo sapiens_hsa00340 | 0.71107725 |
83 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.70908601 |
84 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.68878199 |
85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.68445663 |
86 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.67874205 |
87 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.67438779 |
88 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.66534079 |
89 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.65458158 |
90 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.64811236 |
91 | Asthma_Homo sapiens_hsa05310 | 0.64598989 |
92 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.64002600 |
93 | Endometrial cancer_Homo sapiens_hsa05213 | 0.63824072 |
94 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.61530295 |
95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60993952 |
96 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60801107 |
97 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.60775096 |
98 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.60720498 |
99 | Retinol metabolism_Homo sapiens_hsa00830 | 0.60672165 |
100 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.60417922 |
101 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58865818 |
102 | Alcoholism_Homo sapiens_hsa05034 | 0.57344408 |
103 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.56279560 |
104 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.56147133 |
105 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.55905991 |
106 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.55273564 |
107 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.54445939 |
108 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.54427251 |
109 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.53389141 |
110 | Colorectal cancer_Homo sapiens_hsa05210 | 0.53048291 |
111 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.52521705 |
112 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.52431031 |
113 | Endocytosis_Homo sapiens_hsa04144 | 0.52269317 |
114 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.52232461 |
115 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51731488 |
116 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50632314 |
117 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50173775 |
118 | Prion diseases_Homo sapiens_hsa05020 | 0.49712911 |
119 | Bile secretion_Homo sapiens_hsa04976 | 0.48697904 |
120 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.47592850 |
121 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.45791485 |
122 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.45191516 |
123 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44432682 |
124 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41377746 |
125 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40959346 |
126 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.38707139 |
127 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.38567367 |
128 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.38541273 |
129 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.38090711 |
130 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.37648395 |
131 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.36694599 |
132 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.36081691 |
133 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.35935407 |
134 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.35741435 |
135 | Peroxisome_Homo sapiens_hsa04146 | 0.34583493 |
136 | Platelet activation_Homo sapiens_hsa04611 | 0.34497996 |
137 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.34254141 |
138 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33981226 |
139 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.33062558 |
140 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.32907912 |
141 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.32157848 |
142 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.31681109 |
143 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.29692372 |
144 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.28244820 |
145 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.28157235 |